Source:http://linkedlifedata.com/resource/pubmed/id/19182832
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2009-8-12
|
pubmed:abstractText |
We studied the pharmacokinetic (PK) profile of single daily dose i.v. BU in children who underwent reduced-intensity conditioning (RIC) transplantation. A cohort of 19 patients < or =4 years of age (group 1) and 33 patients >4 years (group 2) was studied. Patients received a BU test dose for PK studies, followed by two treatment doses adjusted to target an area under the curve (AUC) of 4000 microM min per day. Patients in group 1 attained a lower AUC as compared to group 2 (3568 vs 4035 microM min). In group 1, 67% patients and in group 2, 84% patients achieved AUC within the targeted range. Stable donor chimerism was achieved in 56% patients in group 1 and 79% in group 2. Eight patients required a second transplantation because of graft failure. Because of the concern that a low AUC adversely affected outcomes, a second cohort of 23 patients followed a modified protocol with a targeted AUC of 5000 microM min. A higher AUC was attained (4825 microM min). Stable donor chimerism was achieved in 91% of patients. Our results show that RIC regimens using two single daily doses of i.v. BU are effective in children, but a targeted AUC of 5000 microM min is recommended.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1476-5365
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:volume |
44
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
145-56
|
pubmed:meshHeading |
pubmed-meshheading:19182832-Adolescent,
pubmed-meshheading:19182832-Age Factors,
pubmed-meshheading:19182832-Busulfan,
pubmed-meshheading:19182832-Child,
pubmed-meshheading:19182832-Child, Preschool,
pubmed-meshheading:19182832-Disease-Free Survival,
pubmed-meshheading:19182832-Hematopoietic Stem Cell Transplantation,
pubmed-meshheading:19182832-Humans,
pubmed-meshheading:19182832-Infant,
pubmed-meshheading:19182832-Male,
pubmed-meshheading:19182832-Myeloablative Agonists,
pubmed-meshheading:19182832-Neoplasms,
pubmed-meshheading:19182832-Survival Rate,
pubmed-meshheading:19182832-Transplantation Chimera,
pubmed-meshheading:19182832-Transplantation Conditioning,
pubmed-meshheading:19182832-Treatment Outcome
|
pubmed:year |
2009
|
pubmed:articleTitle |
Age-dependent pharmacokinetic profile of single daily dose i.v. busulfan in children undergoing reduced-intensity conditioning stem cell transplant.
|
pubmed:affiliation |
Department of Pediatrics, Children's Memorial Hospital, Northwestern University, Chicago, IL 60614, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|